Centuri Stock Up 18% This Year: What a New $17 Million Position Signals for Investors

Tensile Capital disclosed a new stake in Centuri Holdings of 812,088 shares (~$17.2M), representing roughly 2.2% of its reportable U.S. equity AUM. Centuri (price $25.58, market cap ~$2.5B) reported record Q3 revenue of $850M (+18% YoY), with base revenue up 25%, base gross profit up 28% and a backlog of $5.9B (+59% vs. year-end 2024); management reiterated a $2.8B–$2.9B full-year revenue outlook. The position signals institutional confidence in post-IPO execution and multi-year utility infrastructure demand, but the stake size is modest relative to both Tensile's top holdings and Centuri's market cap.

Analysis

Market structure: Tensile’s $17.2M purchase (812k shares) is a modest vote of confidence in CTRI (market cap ~$2.5B, price $25.58) and signals institutional appetite for utility-infrastructure exposure. Direct winners: Centuri, specialty suppliers (steel, copper, heavy equipment OEMs) and large regulated utilities that outsource upgrades; smaller pure-storm contractors and low-scale regional outfits may lose share as Centuri’s record $5.9B backlog (+59% y/y) gives multiyear revenue visibility. Backlog scale implies tightening supply of skilled crews and upward wage pressure, supporting pricing power but also raising execution risk.

Risk assessment: Key tail risks are regulatory rate-case delays or denials, large project overruns/litigation, and a macro shock that halts utility capex (rates spike or credit squeeze). Immediate (days) impact is muted; short-term (3–12 months) hinges on backlog conversion and Qs results; long-term (2–5 years) depends on sustained utility modernization budgets. Hidden dependencies include backlog composition (firm vs optional work), counterparty concentration, and subcontractor capacity that can compress margins even as revenue grows.

Trade implications: Tradeable idea set: core-long exposure to CTRI sized 1–2% of portfolio to capture backlog conversion, with accumulation on pullbacks to ~$22 (≈-14%). Use options to define risk: buy a 9–15 month bull call spread (e.g., long 12‑15 month 30C, short 40C) to limit cash outlay; alternatively sell a 6‑9 month cash‑secured put at ~$22 to collect premium and potentially buy on a discount. Consider a relative-value pair long CTRI / short MTZ (MasTec) if you prefer betting on superior margin conversion and standalone-growth clarity.

Contrarian angles: Consensus overweights revenue/backlog growth and underweights margin and income volatility—CTRI’s TTM net income is only ~$2.5M, so small cost shocks matter. The market may underprice downside from subcontractor shortages or commodity inflation; conversely, if Centuri executes “One Centuri” integration and converts >50% of backlog into base revenue by 2026, current sub–$26 pricing is likely underdone. Historical spin‑off/post‑IPO peers show lumpy outperformance followed by mean reversion, so size and option structures matter to avoid binary outcomes.

Key Decisions for Investors

• Establish a 1–2% long position in CTRI (Centuri Holdings) over the next 4–8 weeks, targeting an average purchase price of $25.5–$22; scale into position on weakness to $22 (≈-14%) to keep weighted average risk acceptable.
• Implement a defined-risk options trade: buy a 9–15 month bull call spread on CTRI (example: long ~12-month 30C / short 40C) sized to equal ~1% portfolio exposure; this captures upside if backlog converts while capping downside.
• Sell cash‑secured CTRI puts at the $22 strike with a 6–9 month expiry to collect premium and potentially acquire shares at a ~14% discount to current levels; size to conservatively commit cash equal to strike×contracts.
• Consider a 1:1 pair trade—long CTRI vs. short MTZ (MasTec)—for relative exposure to purported superior backlog quality and margin expansion; size the short to offset beta and monitor quarterly backlog conversion and margin KPIs next 2 quarters.